- Home
- ARVN vs KIO Comparison
ARVN vs KIO Comparison
Compare ARVN & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- KIO
- Stock Information
- Founded
- ARVN 2015
- KIO 2011
- Country
- ARVN United States
- KIO United States
- Employees
- ARVN N/A
- KIO 2400
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- KIO Investment Managers
- Sector
- ARVN Health Care
- KIO Finance
- Exchange
- ARVN Nasdaq
- KIO Nasdaq
- Market Cap
- ARVN 456.2M
- KIO 522.7M
- IPO Year
- ARVN 2018
- KIO N/A
- Fundamental
- Price
- ARVN $6.79
- KIO $12.62
- Analyst Decision
- ARVN Buy
- KIO
- Analyst Count
- ARVN 22
- KIO 0
- Target Price
- ARVN $20.21
- KIO N/A
- AVG Volume (30 Days)
- ARVN 2.1M
- KIO 136.5K
- Earning Date
- ARVN 08-06-2025
- KIO 01-01-0001
- Dividend Yield
- ARVN N/A
- KIO 10.82%
- EPS Growth
- ARVN N/A
- KIO N/A
- EPS
- ARVN N/A
- KIO N/A
- Revenue
- ARVN $372,800,000.00
- KIO N/A
- Revenue This Year
- ARVN $7.57
- KIO N/A
- Revenue Next Year
- ARVN N/A
- KIO N/A
- P/E Ratio
- ARVN N/A
- KIO N/A
- Revenue Growth
- ARVN 299.57
- KIO N/A
- 52 Week Low
- ARVN $5.90
- KIO $10.52
- 52 Week High
- ARVN $29.61
- KIO $13.59
- Technical
- Relative Strength Index (RSI)
- ARVN 41.59
- KIO 48.76
- Support Level
- ARVN $6.06
- KIO $12.60
- Resistance Level
- ARVN $7.83
- KIO $12.83
- Average True Range (ATR)
- ARVN 0.40
- KIO 0.08
- MACD
- ARVN -0.11
- KIO -0.02
- Stochastic Oscillator
- ARVN 34.93
- KIO 17.31
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.